Skip to main content

Peer Review reports

From: Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target

Original Submission
26 Oct 2023 Submitted Original manuscript
6 Nov 2023 Reviewed Reviewer Report
25 Nov 2023 Reviewed Reviewer Report - Ismail Erol
30 Dec 2023 Author responded Author comments - Abdul Wadood
Resubmission - Version 2
30 Dec 2023 Submitted Manuscript version 2
1 Jan 2024 Author responded Author comments - Abdul Wadood
Resubmission - Version 3
1 Jan 2024 Submitted Manuscript version 3
7 Jan 2024 Reviewed Reviewer Report - Ismail Erol
27 Jan 2024 Author responded Author comments - Abdul Wadood
Resubmission - Version 4
27 Jan 2024 Submitted Manuscript version 4
30 Jan 2024 Author responded Author comments - Abdul Wadood
Resubmission - Version 5
30 Jan 2024 Submitted Manuscript version 5
30 Jan 2024 Author responded Author comments - Abdul Wadood
Resubmission - Version 6
30 Jan 2024 Submitted Manuscript version 6
13 Feb 2024 Reviewed Reviewer Report - Ismail Erol
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
26 Feb 2024 Editorially accepted
25 Mar 2024 Article published 10.1186/s13065-024-01152-z

You can find further information about peer review here.

Back to article page